West Pharmaceutical Services Inc (WST)
320.88
+9.22
(+2.96%)
USD |
NYSE |
Nov 21, 16:00
325.19
+4.31
(+1.34%)
Pre-Market: 08:55
West Pharmaceutical Services Gross Profit Margin (Quarterly): 35.44% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 35.44% |
| June 30, 2024 | 32.76% |
| March 31, 2024 | 33.10% |
| December 31, 2023 | 38.01% |
| September 30, 2023 | 38.57% |
| June 30, 2023 | 38.66% |
| March 31, 2023 | 37.86% |
| December 31, 2022 | 36.98% |
| September 30, 2022 | 39.02% |
| June 30, 2022 | 41.68% |
| March 31, 2022 | 39.53% |
| December 31, 2021 | 41.13% |
| September 30, 2021 | 40.79% |
| June 30, 2021 | 43.55% |
| March 31, 2021 | 40.54% |
| December 31, 2020 | 36.38% |
| September 30, 2020 | 35.51% |
| June 30, 2020 | 37.01% |
| March 31, 2020 | 33.98% |
| December 31, 2019 | 32.55% |
| September 30, 2019 | 32.41% |
| June 30, 2019 | 33.62% |
| March 31, 2019 | 33.10% |
| December 31, 2018 | 31.53% |
| September 30, 2018 | 31.41% |
| Date | Value |
|---|---|
| June 30, 2018 | 31.78% |
| March 31, 2018 | 32.33% |
| December 31, 2017 | 30.94% |
| September 30, 2017 | 31.42% |
| June 30, 2017 | 31.44% |
| March 31, 2017 | 34.61% |
| December 31, 2016 | 32.36% |
| September 30, 2016 | 32.15% |
| June 30, 2016 | 34.36% |
| March 31, 2016 | 34.05% |
| December 31, 2015 | 33.25% |
| September 30, 2015 | 31.44% |
| June 30, 2015 | 32.86% |
| March 31, 2015 | 32.66% |
| December 31, 2014 | 31.36% |
| September 30, 2014 | 30.88% |
| June 30, 2014 | 33.02% |
| March 31, 2014 | 30.68% |
| December 31, 2013 | 31.11% |
| September 30, 2013 | 30.87% |
| June 30, 2013 | 32.19% |
| March 31, 2013 | 32.91% |
| December 31, 2012 | 30.33% |
| September 30, 2012 | 29.76% |
| June 30, 2012 | 30.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
32.55%
Minimum
Dec 2019
43.55%
Maximum
Jun 2021
37.65%
Average
37.93%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Repligen Corp | 50.03% |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | -0.14% |
| Xtant Medical Holdings Inc | 58.37% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.16% |
| Return on Assets | 13.61% |
| Return on Invested Capital | 16.89% |
| Profit Margin (Quarterly) | 18.21% |
| Operating Margin (Quarterly) | 22.18% |
| Return on Net Operating Assets | 18.53% |